Medicare dental insurance
About.com Health Insurance: What's Hot Now
These articles that had the largest increase in popularity over the last week
- AHPs
Learn about the pros and cons to buying health coverage through an association health plan. - Arkansas
Contact information for state offices and resources for obtaining and keeping health insurance in Arkansas. - History of Job-Based Coverage
Find out why America's health care system relies so heavily on employer sponsored, job-based coverage. The answer lies in mid-20th century history. - Medicare Advantage
Learn more about Medicare Advantage plans, including how they work and what they cover.
Latest Insurance Questions discussions
- coverage
I have a 66 year old uncle with Glioblastoma multiforme. He is currently under going radiation an chemotherapy. In the hospital they had him on Temodar. They released him from the hospital about 4 days ago but now his medicare and medicaid don't want to pay for the Temodar, is there a reason for this? Is there something i can do to have them pay for the drug cause my family can't afford it? - Desperate Patient Needs Tarceva..Please share any info you may have....
My uncle was just diagnosed with Stage 4 lung cancer and severe/widespread bone metastases. It has spread everywhere in his body except his neck, toes and head. For some reason, he didn't show or complain about the symptoms one would have expected, which is why they didn't detect it until now. But the reality is he is in a country that is so upside down and backwards that in this day and age, we still suffer from such draconian access to medical services.They are giving him 30 to 60 days to live but it's possible that Tarceva will push that out to 6 to 9 months. He is very late stage, unbearable and difficult to control pain, unable to eat, very difficult to breath, very weak and very little body weight left. He is 59. I have been turning my life inside out trying to find a way to gain access to Tarceva. It is impossibly expensive at $3,300 per month. Genentech, the US distributor, has a foundation to assist the needy in the United States.Roche, the distributor for the rest of the world, does not have this type of charity foundation.I am desperate and so is my family and I don't know where else to turn but to those of you that have gone through this and understand what's happening.The United Nations states that access to critical, life sustaining medications is an inalienable human right for every person on this planet. What do I do?Is there any way to get access to even a small quantity of Tarceva?I mean, even if I sold every worldly posession I had, it would buy him only two months worth of Tarceva.I can't accept that our world is like this. It just doesn't make any sense.Any advice would be very welcome. Thanks in advance. Pej - Any from covered by PPHA?
Is there anyone out there covered by PPHA and has had cytoreduction and/or Intraperitoneal hyperthermic chemotherapy covered and paid for by PPHA (Progressive Personal Helathcare Advocates)? We have been denied coverage. :(Thanks for any help.M.F. - Medicare Modernization Act
Medicare Modernization Act Did Not Change Chemotherapy As Feared DURHAM, N.C. -- Cancer patients receiving chemotherapy have not noticed a restriction in their access to treatment following the enactment of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), despite the act's significant reduction in government reimbursement to oncologists, according to a new study led by researchers in the Duke Clinical Research Institute (DCRI). "Critics of the MMA often said that it would reduce patients' access to chemotherapy services, because doctors would receive 30 to 40 percent less reimbursement from the government for administering treatment," said Kevin Schulman, M.D., director of the DCRI's Center for Clinical and Genetic Economics, and senior investigator on the study. "Our study showed that patients actually do not perceive barriers to their access to chemotherapy and perceptions about access are really the same among patients who received treatment before the legislation went into effect, and those who received it afterwards." The team's findings will be published in the November 15, 2007 print edition of the journal Cancer, but also will appear earlier in the journal's October 8, 2007 online edition. The study was funded by a grant from the National Patient Advocate Foundation's Global Access Project, which brings together 42 national healthcare stakeholder groups -- such as pharmaceutical companies and advocacy groups -- to fund health research projects. The Project has focused on examining the MMA's consequences for patients, providers and healthcare systems. The Duke researchers examined the results of 1421 surveys completed via the internet by 684 patients who had received chemotherapy prior to the enactment of the MMA and 737 patients who were treated after it went into effect. Respondents answered questions related to issues including the amount of time they waited to start chemotherapy after their initial cancer diagnosis, and how far they had to travel to get their treatments. "When the act was passed in 2003, many doctors and patient advocates were concerned about the consolidation of services it might necessitate, such as the moving of chemotherapy services to hospital rather than outpatient settings and the elimination of staff positions," said Joelle Friedman, a DCRI researcher and lead author on the paper. "They were afraid these changes would affect patients' access to care, but our study showed that these concerns turned out to be largely unwarranted." About half of the patients surveyed in each group were under the age of 65 and half were over 65. The majority of patients in each group reported being either satisfied or very satisfied with the care they received from their oncologists, Friedman said. The researchers also found no difference in the amount of time from diagnosis to initiation of chemotherapy between the two groups; the median lapse in time was 22 days in both groups, Friedman said. Patients reported an average travel time of 30 minutes to the location of their chemotherapy appointments, both before and after the implementation of the act, she said. The speculation that treatment location would change -- that patients would either be forced to travel farther for therapy or switch treatment locations in the middle of therapy -- also proved to be unfounded, Friedman said. The MMA represented the largest overhaul of the Medicare system since it was created in 1965. Changes included a new prescription drug benefit, and a $25 billion allocation of funds to rural hospitals. One key provision, however, was a significant reduction in Medicare reimbursement to healthcare providers. Oncologists were strongly affected, due to a perception that they had been over-compensated in the past. Other researchers involved with this study were Lesley Curtis, Bradley Hammill, Jatinder Dhillon, Charles Weaver, Sugata Biswas and Amy Abernethy. - URGENT HELP NEEDED PLEASE
My brother has surgery in March and has a recurrent malignant brain tunor Grade IV. He has been denied for Avastin/CPT-11 treatment and we have a hearing tomorrow with Blue Cross/Blue Shield. He is progressively getting worse every day and we are looking for facts for tomorrow's hearing. Does anyone know what insurance companies will cover Avastin? The doctor feels this is his best hope. Please let us know. Debbie - Free Chemo Medication
We no longer have insurance and could not afford my husband's Temador. We found Schering's Commitment to Care Program. They are now mailing us his Temador free. There # is (800) 521-7157. I hope this helps someone. Diane - Issels Clinic in Santa Barbara
Anyone familiar with this clinic and its protcols, please be kind enough to enlighten me. Does Medicare cover this clinic and whatever fees (hospitalization). Thank you. Please respond. - Uninsured or UnderInsured?
If you are looking for a way to save money on Medical,RX,Vision and or dental please contact me. i will show you how me and my family save money on these services.ThankssandySandya1967@aol.com - Inconclusive CT scan
Hello! My name is Megg. I am a 30 yo female with a golf ball size lump just above my collar bone. This started out as a pea sized lump in November. I finally decided to seek the advice of my dr. He sent me to get a CT scan with contrast and it came back inconclusive. I am so confused and wondering if I should seek another opinion. Has anyone else had inconclusive (i.e. didn;t show up on the scan) ct results? Please, any advice , thoughts would be so greatly appreciated. all the best,megg - PSA and Medicare
As I am watchful waiting with a very high PSA (60), it is necessary to have a PSA test every three months. Medicare will only approve one test per year. Does anyone know how to gain approval for more than one PSA per year?Will appreciate your help.George - coinsurance
The latest insurance policies req
